NDATOPICALLOTION
Approved
Dec 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 19h ago · AI intelligence enriched Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
KLARON is a topical lotion containing sodium sulfacetamide, a sulfonamide antibiotic used to treat bacterial skin infections and acne-related conditions. Applied directly to affected skin areas, it works by inhibiting bacterial protein synthesis. The product has been marketed since 1996 and remains a standard option in dermatological practice.
LOE Approaching
With LOE approaching and moderate competitive pressure (30), this product faces declining revenue potential, likely resulting in smaller team size and transition-focused roles.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on KLARON as a pharmaceutical professional means supporting a mature, LOE-approaching asset with limited growth opportunities. Career advancement typically requires managing decline, optimizing efficiency, and potentially transitioning to higher-priority pipeline assets or competitive brands.
Brand ManagerProduct Manager
Worked on KLARON at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.